Rheumatoid Arthritis Industry, April 2015 Market Reports from Top Publishers

You might be interested in: Biosimilar, Diagnostics, Drug, Pharmaceutical, Orthopedic Prosthesis, Antibody, Biosimilars, Cell Therapy, Clinical Trial, Monoclonal Antibody, Pain Management Therapeutics, Sports Medicine, Therapy.


 
1-10 of 61 reports for Rheumatoid Arthritis

Purchase Reports From Reputable Market Research Publishers

Sjogren%s Syndrome - Pipeline Review, H2 2014

Sjogren%s Syndrome - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Sjogren's Syndrome - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Sjogren's Syndrome - Pipeline Review, H2 2014’, provides an overview of the Sjogren's Syndrome’s therapeutic pipeline. ...

Rheumatoid Arthritis-API Insights, 2015

Rheumatoid Arthritis-API Insights, 2015

  • $ 1 250
  • Industry report
  • April 2015
  • by Delve Insight

Summary DelveInsight’s, Rheumatoid Arthritis-API Insights, 2015,report provides Rheumatoid Arthritis drugs marketed details and API Manufacturers details across the globe along with the location. The ...

Juvenile Rheumatoid Arthritis-API Insights, 2015

Juvenile Rheumatoid Arthritis-API Insights, 2015

  • $ 1 250
  • Industry report
  • April 2015
  • by Delve Insight

Summary DelveInsight’s, Juvenile Rheumatoid Arthritis-API Insights, 2015,report provides Juvenile Rheumatoid Arthritis drugs marketed details and API Manufacturers details across the globe along with ...

Systemic Juvenile Rheumatoid Arthritis-API Insights, 2015

Systemic Juvenile Rheumatoid Arthritis-API Insights, 2015

  • $ 1 250
  • Industry report
  • April 2015
  • by Delve Insight

Summary DelveInsight’s, Systemic Juvenile Rheumatoid Arthritis-API Insights, 2015,report provides Systemic Juvenile Rheumatoid Arthritis drugs marketed details and API Manufacturers details across the ...

 Juvenile Rheumatoid Arthritis-Pipeline Insights, 2015

Juvenile Rheumatoid Arthritis-Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • April 2015
  • by Delve Insight

SUMMARY DelveInsight’s, “ Juvenile Rheumatoid Arthritis-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this Juvenile Rheumatoid Arthritis. A key objective ...

The 2016-2021 World Outlook for Rheumatoid Arthritis Therapeutics

The 2016-2021 World Outlook for Rheumatoid Arthritis Therapeutics

  • $ 995
  • Industry report
  • April 2015
  • by ICON Group

This econometric study covers the world outlook for Rheumatoid Arthritis therapeutics across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry ...

Systemic Juvenile Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Systemic Juvenile Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight’s, “Systemic Juvenile Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs ...

Juvenile Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Juvenile Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight’s, “Juvenile Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight’s, “Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

PharmaPoint: Rheumatoid Arthritis - US Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - US Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - US Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

About 3 400 reports for Rheumatoid Arthritis

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Canada

  • January 2014
    200 pages
  • Arthritis  

    Musculoskeletal...  

    Autoimmune Dise...  

  • Canada  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.